Therapeutic considerations in the management of agitated or delirious critically ill patients

Agitation and delirium in the critical care unit are common problems that at times are difficult to treat. The difficulty stems from few placebo-controlled or even blinded trials evaluating various therapies. In addition, the literature in these areas is scattered through various journals in a varie...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacotherapy 1998, Vol.18 (1), p.113-129
Main Authors: HASSAN, E, FONTAINE, D. K, NEARMAN, H. S
Format: Article
Language:English
Subjects:
Anti-Anxiety Agents - therapeutic use
Anxiety Disorders - therapy
Benzodiazepines - therapeutic use
Biological and medical sciences
Clinical Trials as Topic
Critical Care
Critical Illness
Delirium - therapy
General aspects
Humans
Intensive Care Units
Medical sciences
Narcotics - therapeutic use
Neuropharmacology
Pharmacology. Drug treatments
Propofol - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 129
container_issue 1
container_start_page 113
container_title Pharmacotherapy
container_volume 18
creator HASSAN, E
FONTAINE, D. K
NEARMAN, H. S
description Agitation and delirium in the critical care unit are common problems that at times are difficult to treat. The difficulty stems from few placebo-controlled or even blinded trials evaluating various therapies. In addition, the literature in these areas is scattered through various journals in a variety of disciplines. Pharmacologic and nonpharmacologic techniques may achieve the therapeutic objective for these patients. Since no one drug will achieve the goals in every patient, therapy must be tailored to the characteristics and needs of each individual.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79684514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79684514</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-d110e63ad9c7877057765c7444b7e20ce70fd7606fbc854d917a33c403d1b7353</originalsourceid><addsrcrecordid>eNo9kM1LxDAQxYMo67r6Jwg5iLdC0qSZ9iiLX7DgZT1KSZPpbiT9MMke9r83YPE0M7wfj3nvgqx5DVXRcC4vyZqVAAVjrL4mNzF-M1ZyJcsVWTVSNapWa_K1P2LQM56SM9RMY3Q238nljbqRpiPSQY_6gAOOiU491QeXdEJLp0AtehfcdIrUBJcNtPdn6rync3bIfLwlV732Ee-WuSGfL8_77Vux-3h93z7tirkUVSos5wyV0LYxUAOwCkBVBqSUHWDJDALrLSim-s7UlbQNBy2EkUxY3oGoxIY8_vnOYfo5YUzt4KJB7_WI-b0WclhZcZnB-wU8dQPadg5u0OHcLn1k_WHRdcxx-qBH4-I_VnLBBFPiF6Vuan8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79684514</pqid></control><display><type>article</type><title>Therapeutic considerations in the management of agitated or delirious critically ill patients</title><source>Wiley</source><creator>HASSAN, E ; FONTAINE, D. K ; NEARMAN, H. S</creator><creatorcontrib>HASSAN, E ; FONTAINE, D. K ; NEARMAN, H. S</creatorcontrib><description>Agitation and delirium in the critical care unit are common problems that at times are difficult to treat. The difficulty stems from few placebo-controlled or even blinded trials evaluating various therapies. In addition, the literature in these areas is scattered through various journals in a variety of disciplines. Pharmacologic and nonpharmacologic techniques may achieve the therapeutic objective for these patients. Since no one drug will achieve the goals in every patient, therapy must be tailored to the characteristics and needs of each individual.</description><identifier>ISSN: 0277-0008</identifier><identifier>EISSN: 1875-9114</identifier><identifier>PMID: 9469686</identifier><identifier>CODEN: PHPYDQ</identifier><language>eng</language><publisher>Boston, MA: Pharmacotherapy</publisher><subject>Anti-Anxiety Agents - therapeutic use ; Anxiety Disorders - therapy ; Benzodiazepines - therapeutic use ; Biological and medical sciences ; Clinical Trials as Topic ; Critical Care ; Critical Illness ; Delirium - therapy ; General aspects ; Humans ; Intensive Care Units ; Medical sciences ; Narcotics - therapeutic use ; Neuropharmacology ; Pharmacology. Drug treatments ; Propofol - therapeutic use</subject><ispartof>Pharmacotherapy, 1998, Vol.18 (1), p.113-129</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2130306$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9469686$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HASSAN, E</creatorcontrib><creatorcontrib>FONTAINE, D. K</creatorcontrib><creatorcontrib>NEARMAN, H. S</creatorcontrib><title>Therapeutic considerations in the management of agitated or delirious critically ill patients</title><title>Pharmacotherapy</title><addtitle>Pharmacotherapy</addtitle><description>Agitation and delirium in the critical care unit are common problems that at times are difficult to treat. The difficulty stems from few placebo-controlled or even blinded trials evaluating various therapies. In addition, the literature in these areas is scattered through various journals in a variety of disciplines. Pharmacologic and nonpharmacologic techniques may achieve the therapeutic objective for these patients. Since no one drug will achieve the goals in every patient, therapy must be tailored to the characteristics and needs of each individual.</description><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>Anxiety Disorders - therapy</subject><subject>Benzodiazepines - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Critical Care</subject><subject>Critical Illness</subject><subject>Delirium - therapy</subject><subject>General aspects</subject><subject>Humans</subject><subject>Intensive Care Units</subject><subject>Medical sciences</subject><subject>Narcotics - therapeutic use</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Propofol - therapeutic use</subject><issn>0277-0008</issn><issn>1875-9114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9kM1LxDAQxYMo67r6Jwg5iLdC0qSZ9iiLX7DgZT1KSZPpbiT9MMke9r83YPE0M7wfj3nvgqx5DVXRcC4vyZqVAAVjrL4mNzF-M1ZyJcsVWTVSNapWa_K1P2LQM56SM9RMY3Q238nljbqRpiPSQY_6gAOOiU491QeXdEJLp0AtehfcdIrUBJcNtPdn6rync3bIfLwlV732Ee-WuSGfL8_77Vux-3h93z7tirkUVSos5wyV0LYxUAOwCkBVBqSUHWDJDALrLSim-s7UlbQNBy2EkUxY3oGoxIY8_vnOYfo5YUzt4KJB7_WI-b0WclhZcZnB-wU8dQPadg5u0OHcLn1k_WHRdcxx-qBH4-I_VnLBBFPiF6Vuan8</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>HASSAN, E</creator><creator>FONTAINE, D. K</creator><creator>NEARMAN, H. S</creator><general>Pharmacotherapy</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Therapeutic considerations in the management of agitated or delirious critically ill patients</title><author>HASSAN, E ; FONTAINE, D. K ; NEARMAN, H. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-d110e63ad9c7877057765c7444b7e20ce70fd7606fbc854d917a33c403d1b7353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>Anxiety Disorders - therapy</topic><topic>Benzodiazepines - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Critical Care</topic><topic>Critical Illness</topic><topic>Delirium - therapy</topic><topic>General aspects</topic><topic>Humans</topic><topic>Intensive Care Units</topic><topic>Medical sciences</topic><topic>Narcotics - therapeutic use</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Propofol - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HASSAN, E</creatorcontrib><creatorcontrib>FONTAINE, D. K</creatorcontrib><creatorcontrib>NEARMAN, H. S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HASSAN, E</au><au>FONTAINE, D. K</au><au>NEARMAN, H. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic considerations in the management of agitated or delirious critically ill patients</atitle><jtitle>Pharmacotherapy</jtitle><addtitle>Pharmacotherapy</addtitle><date>1998</date><risdate>1998</risdate><volume>18</volume><issue>1</issue><spage>113</spage><epage>129</epage><pages>113-129</pages><issn>0277-0008</issn><eissn>1875-9114</eissn><coden>PHPYDQ</coden><abstract>Agitation and delirium in the critical care unit are common problems that at times are difficult to treat. The difficulty stems from few placebo-controlled or even blinded trials evaluating various therapies. In addition, the literature in these areas is scattered through various journals in a variety of disciplines. Pharmacologic and nonpharmacologic techniques may achieve the therapeutic objective for these patients. Since no one drug will achieve the goals in every patient, therapy must be tailored to the characteristics and needs of each individual.</abstract><cop>Boston, MA</cop><pub>Pharmacotherapy</pub><pmid>9469686</pmid><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0277-0008
ispartof Pharmacotherapy, 1998, Vol.18 (1), p.113-129
issn 0277-0008
1875-9114
language eng
recordid cdi_proquest_miscellaneous_79684514
source Wiley
subjects Anti-Anxiety Agents - therapeutic use
Anxiety Disorders - therapy
Benzodiazepines - therapeutic use
Biological and medical sciences
Clinical Trials as Topic
Critical Care
Critical Illness
Delirium - therapy
General aspects
Humans
Intensive Care Units
Medical sciences
Narcotics - therapeutic use
Neuropharmacology
Pharmacology. Drug treatments
Propofol - therapeutic use
title Therapeutic considerations in the management of agitated or delirious critically ill patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A00%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20considerations%20in%20the%20management%20of%20agitated%20or%20delirious%20critically%20ill%20patients&rft.jtitle=Pharmacotherapy&rft.au=HASSAN,%20E&rft.date=1998&rft.volume=18&rft.issue=1&rft.spage=113&rft.epage=129&rft.pages=113-129&rft.issn=0277-0008&rft.eissn=1875-9114&rft.coden=PHPYDQ&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E79684514%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p235t-d110e63ad9c7877057765c7444b7e20ce70fd7606fbc854d917a33c403d1b7353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79684514&rft_id=info:pmid/9469686&rfr_iscdi=true